Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Zoetis logoZoetis ZTS

The company said it appointed Jamie Brannan to the newly created role of Executive Vice President and Chief Commercial Officer, effective immediately, on November 11, 2024. The role oversees all commercial markets across the globe, including the United States and all International markets.

8-KChanges in Control of RegistrantFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said it appointed Jamie Brannan to the newly created role of Executive Vice President and Chief Commercial Officer, effective immediately, on November 11, 2024. The role oversees all commercial markets across the globe, including the United States and all International markets.

  2. Zoetis said Wafaa Mamilli, Executive Vice President, Chief Digital & Technology Officer and Group President for China, Brazil and Precision Animal Health, has informed the company that she will leave in early 2025 to pursue an external opportunity. Keith Sarbaugh was promoted to Chief Digital & Technology Officer effective immediately.

  3. The company said Ester Banque, Executive Vice President and President, U.S. Operations, will leave the company and serve in an advisory capacity until early 2025. Jared Shriver was promoted to President, U.S. Operations, effective immediately, and reports to Mr. Brannan.

  4. Zoetis said Mr. Sarbaugh joined the company in March 2023, previously serving as Vice President and Chief Information Officer, and has nearly 25 years of technology and digital leadership experience. Before his promotion, Mr. Shriver was Senior Vice President of U.S. Livestock, Bio Devices, Equine, and Platinum Performance, in his nearly 20-year tenure.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Jamie Brannan Named Chief Commercial Officer in Newly Created Role

The company said it appointed Jamie Brannan to the newly created role of Executive Vice President and Chief Commercial Officer, effective immediately, on November 11, 2024. The role oversees all commercial markets across the globe, including the United States and all International markets.

Source · Based on the filing body and exhibits

Wafaa Mamilli to Leave in Early 2025; Keith Sarbaugh Promoted

Zoetis said Wafaa Mamilli, Executive Vice President, Chief Digital & Technology Officer and Group President for China, Brazil and Precision Animal Health, has informed the company that she will leave in early 2025 to pursue an external opportunity. Keith Sarbaugh was promoted to Chief Digital & Technology Officer effective immediately.

Source · Based on the filing body and exhibits

Ester Banque Steps Down; Jared Shriver Named President, U.S. Operations

The company said Ester Banque, Executive Vice President and President, U.S. Operations, will leave the company and serve in an advisory capacity until early 2025. Jared Shriver was promoted to President, U.S. Operations, effective immediately, and reports to Mr. Brannan.

Source · Based on the filing body and exhibits

Background of Keith Sarbaugh and Jared Shriver

Zoetis said Mr. Sarbaugh joined the company in March 2023, previously serving as Vice President and Chief Information Officer, and has nearly 25 years of technology and digital leadership experience. Before his promotion, Mr. Shriver was Senior Vice President of U.S. Livestock, Bio Devices, Equine, and Platinum Performance, in his nearly 20-year tenure.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.